Lichtman AH - Search Results

1

Genetic Knockout of Fatty Acid Amide Hydrolase Ameliorates Cisplatin-Induced Nephropathy in Mice.

Chen C, Wang W, Raymond M, Ahmadinejad F, Poklis JL, Em B, Gewirtz DA, Lichtman AH, Li N. Chen C, et al. Among authors: lichtman ah. Mol Pharmacol. 2023 Apr;103(4):230-240. doi: 10.1124/molpharm.122.000618. Epub 2023 Jan 26. Mol Pharmacol. 2023. PMID: 36702548 Free PMC article.

2

Pharmacological evaluation of aerosolized cannabinoids in mice.

Lichtman AH, Peart J, Poklis JL, Bridgen DT, Razdan RK, Wilson DM, Poklis A, Meng Y, Byron PR, Martin BR. Lichtman AH, et al. Eur J Pharmacol. 2000 Jul 7;399(2-3):141-9. doi: 10.1016/s0014-2999(00)00321-6. Eur J Pharmacol. 2000. PMID: 10884513

3

The pharmacological activity of inhalation exposure to marijuana smoke in mice.

Lichtman AH, Poklis JL, Poklis A, Wilson DM, Martin BR. Lichtman AH, et al. Drug Alcohol Depend. 2001 Jul 1;63(2):107-16. doi: 10.1016/s0376-8716(00)00205-2. Drug Alcohol Depend. 2001. PMID: 11376914

4

Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.

Lichtman AH, Hawkins EG, Griffin G, Cravatt BF. Lichtman AH, et al. J Pharmacol Exp Ther. 2002 Jul;302(1):73-9. doi: 10.1124/jpet.302.1.73. J Pharmacol Exp Ther. 2002. PMID: 12065702

5

Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity.

Lichtman AH, Leung D, Shelton CC, Saghatelian A, Hardouin C, Boger DL, Cravatt BF. Lichtman AH, et al. J Pharmacol Exp Ther. 2004 Nov;311(2):441-8. doi: 10.1124/jpet.104.069401. Epub 2004 Jun 30. J Pharmacol Exp Ther. 2004. PMID: 15229230

6

Fatty acid amide hydrolase (-/-) mice exhibit an increased sensitivity to the disruptive effects of anandamide or oleamide in a working memory water maze task.

Varvel SA, Cravatt BF, Engram AE, Lichtman AH. Varvel SA, et al. Among authors: lichtman ah. J Pharmacol Exp Ther. 2006 Apr;317(1):251-7. doi: 10.1124/jpet.105.095059. Epub 2005 Dec 13. J Pharmacol Exp Ther. 2006. PMID: 16352706

7

Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors.

Wise LE, Shelton CC, Cravatt BF, Martin BR, Lichtman AH. Wise LE, et al. Among authors: lichtman ah. Eur J Pharmacol. 2007 Feb 14;557(1):44-8. doi: 10.1016/j.ejphar.2006.11.002. Epub 2006 Nov 10. Eur J Pharmacol. 2007. PMID: 17217945

8

Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception.

Naidu PS, Booker L, Cravatt BF, Lichtman AH. Naidu PS, et al. Among authors: lichtman ah. J Pharmacol Exp Ther. 2009 Apr;329(1):48-56. doi: 10.1124/jpet.108.143487. Epub 2008 Dec 31. J Pharmacol Exp Ther. 2009. PMID: 19118134 Free PMC article.

9

Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation.

Schlosburg JE, Kinsey SG, Lichtman AH. Schlosburg JE, et al. Among authors: lichtman ah. AAPS J. 2009 Mar;11(1):39-44. doi: 10.1208/s12248-008-9075-y. Epub 2009 Jan 29. AAPS J. 2009. PMID: 19184452 Free PMC article. Review.

10

Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.

Kinsey SG, Long JZ, O'Neal ST, Abdullah RA, Poklis JL, Boger DL, Cravatt BF, Lichtman AH. Kinsey SG, et al. Among authors: lichtman ah. J Pharmacol Exp Ther. 2009 Sep;330(3):902-10. doi: 10.1124/jpet.109.155465. Epub 2009 Jun 5. J Pharmacol Exp Ther. 2009. PMID: 19502530 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

359 results

Search Page